OmniAb (OABI) Other Operating Expenses (2021 - 2026)
OmniAb (OABI) reported Other Operating Expenses of $46000.0 for Q1 2026, down 93.87% year-over-year from $750000.0 in Q1 2025, and up 129.3% on a QoQ basis from -$157000.0 in Q4 2025.
OmniAb (OABI) has 6 years of Other Operating Expenses data on file, last reported at $46000.0 in Q1 2026.
- Quarterly Other Operating Expenses fell 93.87% year-over-year to $46000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 41.78% YoY) and the FY2025 annual result came in at $2.5 million, up 7.78% from the prior year.
- Other Operating Expenses improved to $46000.0 in Q1 2026 per OABI's latest filing, from -$157000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $2.5 million in Q2 2024 and bottomed at -$165000.0 in Q2 2022.
- The 5-year median for Other Operating Expenses is $34000.0 (2025), against an average of $315352.9.
- Peak annual rise in Other Operating Expenses reached 5589.7% in 2022, while the deepest fall reached 7651.49% in 2022.
- Tracing OABI's Other Operating Expenses over 5 years: stood at $106000.0 in 2022, then slumped by 86.79% to $14000.0 in 2023, then jumped by 192.86% to $41000.0 in 2024, then tumbled by 482.93% to -$157000.0 in 2025, then jumped by 129.3% to $46000.0 in 2026.
- Per Business Quant, the three latest OABI Other Operating Expenses figures stand at $46000.0 (Q1 2026), -$157000.0 (Q4 2025), and $34000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | OmniAb | 334.72 Mn | 291.75 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46,000.00 |
| Dec 31, 2025 | -157,000.00 |
| Sep 30, 2025 | 34,000.00 |
| Jun 30, 2025 | 1.92 Mn |
| Mar 31, 2025 | 750,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | -146,000.00 |
| Jun 30, 2024 | 2.52 Mn |
| Mar 31, 2024 | -54,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | -16,000.00 |
| Jun 30, 2023 | -140,000.00 |
| Mar 31, 2023 | -49,000.00 |
| Dec 31, 2022 | 106,000.00 |
| Sep 30, 2022 | 208,000.00 |
| Jun 30, 2022 | -165,000.00 |
| Mar 31, 2022 | 443,000.00 |
| Dec 31, 2021 | 70.18 Mn |
| Sep 30, 2021 | 170,579.00 |
| Jun 30, 2021 | 2,185.00 |
| Mar 31, 2021 | 7,786.00 |